Concepedia

Mandy Stanske

MS

5

Publications

121

Citations

5

H-Index

2017

Active since

Affiliations

Charité - Universitätsmedizin Berlin(Current)

KU Leuven

Universität Hamburg

Sapienza University of Rome

University Medical Center Hamburg-Eppendorf

Mandy Stanske is an author at Charité - Universitätsmedizin Berlin specializing in tumor biology, cancer therapeutics, and oncology.

Top concepts

Publications per year

2017–2019

5

Publications

5

Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy–Innovative Models Prolong Survival (OCTIPS) Consortium

Ilary Ruscito, Dan Cacsire Castillo‐Tong, Ignace Vergote et al. · European Journal of Cancer · 2017 · 39 citations · Full text

, , +8

Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer

Mandy Stanske, Stephan Wienert, Dan Cacsire Castillo‐Tong et al. · Neoplasia · 2018 · 28 citations · Full text

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).

Ilary Ruscito, Dan Cacsire Castillo‐Tong, Ignace Vergote et al. · British Journal of Cancer · 2018 · 22 citations · Full text

Morphology and tumour‐infiltrating lymphocytes in high‐stage, high‐grade serous ovarian carcinoma correlated with long‐term survival

Silvia Darb‐Esfahani, Ivonne Kolaschinski, Fabian Trillsch et al. · Histopathology · 2018 · 17 citations · Full text

Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium

Jun Guan, Silvia Darb‐Esfahani, Rolf Richter et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 15 citations · Full text

, , +6

Rows per page

1–5 of 5